サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1510758

欧州のマラリア治療薬市場：2030年予測と地域別分析：治療薬別、投与経路別、流通チャネル別

Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日
ページ情報
英文 87 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
欧州のマラリア治療薬市場：2030年予測と地域別分析：治療薬別、投与経路別、流通チャネル別
出版日: 2024年05月07日
発行: The Insight Partners
ページ情報: 英文 87 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のマラリア治療薬市場は、2022年に4億5,169万米ドルと評価され、2030年には30億6,097万米ドルに達すると予測され、2022年から2030年までのCAGRは27.0%で成長すると推定されます。

新薬とワクチンのパイプラインが欧州のマラリア治療薬市場を牽引

抗菌薬耐性は、マラリアのような多くの疾病のリスクにさらされる可能性があります。この課題を克服するためには、新薬の研究開発が最良の戦略と考えられており、その結果、抗マラリア薬のパイプラインはますます強固なものになってきています。その結果、抗マラリア薬のパイプラインはますます充実してきています。官民パートナーシップは、マラリア治療に関する研究活動を加速させています。例えば、非営利団体であるMedicines for Malaria Venture（MMV）は、多くの製薬会社と協力し、新しい治療法を開発することでマラリアの負担を軽減しています。

臨床開発中の抗マラリア薬の一部を下表に示す：

  • 表1.臨床開発中のマラリア治療薬／ワクチン／化合物

薬剤開発者臨床試験段階

アルテフェノメルサノフィフェーズⅡb

KAE609ノバルティス社Phase IIb

KAF156ノバルティス社Phase IIb

DSM265武田薬品工業第Ⅱa相

SANARIA PfSPZ-GA1サナリア第Ⅱ相

SANARIA PfSPZワクチン- 放射線誘発PfSPZワクチンSanaria Phase II

サナリア PfSPZ-CVacサナリアフェーズ II

MSP3-CRM-Vac4All Vac4All Phase I

肝期抗原-3（LSA3）Vac4All Phase IIa

出典会社ウェブサイト、インサイト・パートナーズ分析

したがって、臨床開発中の抗マラリア薬や薬剤/ワクチンの数が増加していることが、今後の市場成長を押し上げると予想されます。

欧州のマラリア治療薬市場概要

ECDCのサーベイランスレポートによると、フランスは2020年に最も多くのマラリア患者を報告しました。2020年、フランスは1,007件のマラリア確定症例を報告しました。2020年にEU/EEA諸国から報告されたほぼすべての症例は、他国からフランスに渡航した人々から診断されたもので、これらの多くは西アフリカからの渡航経路に関連した人々でした。フランスでは、P.falciparumが旅行者の重症例と死亡例のほとんどを引き起こしています。多くの研究機関が、フランスにおけるマラリア撲滅に向けた新たなアプローチの開発に取り組んでいます。例えば、パスツール研究所のチームはワクチン開発を目的としたマラリア研究に専念しています。この調査は、マラリアと闘う新しい方法を見つけるために不可欠です。パスツール研究所はまた、欧州7カ国の17の研究機関と大学、アフリカ3カ国のパートナーが参加する、EVIMalaRと名付けられた欧州の大規模プログラムにも参加しています。このようなマラリア撲滅に向けた協力的な取り組みが、フランスのマラリア治療市場の成長を促進しています。

欧州のマラリア治療薬市場の収益と2030年までの予測

欧州のマラリア治療薬市場のセグメンテーション

欧州のマラリア治療薬市場は、治療法、投与経路、流通チャネル、国に基づいて細分化されます。治療法に基づき、欧州のマラリア治療薬市場はジェネリック医薬品、先発医薬品、ワクチン、その他に区分されます。2022年にはジェネリック医薬品分野が最大の市場シェアを占めています。

投与経路では、欧州のマラリア治療薬市場は経口薬と非経口薬に二分されます。2022年の市場シェアは経口剤セグメントが大きいです。

流通チャネル別では、欧州のマラリア治療薬市場は直接入札、病院薬局、小売薬局、オンライン薬局、その他に区分されます。直接入札セグメントが2022年に最大の市場シェアを占めました。

国別では、欧州のマラリア治療薬市場は英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。フランスが2022年の欧州のマラリア治療薬市場シェアを独占しました。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、Sanofi SA、GSK Plc、Novartis AG、Pfizer Inc、Lupin Ltdは、欧州のマラリア治療薬市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察-マラリア

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のマラリア治療薬市場- 主要産業力学

  • 主な市場促進要因
    • マラリアの有病率の増加
  • 市場抑制要因
    • 抗マラリア薬の偽造品の入手可能性とその後の薬剤耐性
  • 市場機会
    • 市場企業による戦略的イニシアチブの高まり
  • 今後の動向
    • 新薬とワクチンのパイプラインの拡大
  • 影響分析

第5章 マラリア治療市場：欧州市場分析

  • 欧州のマラリア治療薬市場売上高、2022年～2030年

第6章 欧州のマラリア治療薬市場：2030年までの収益と予測：治療薬別

  • ワクチン
  • ジェネリック医薬品
  • 先発医薬品
  • その他

第7章 欧州のマラリア治療薬市場：2030年までの収益と予測：投与経路別

  • 経口剤
  • 非経口剤

第8章 欧州のマラリア治療薬市場：2030年までの収益と予測：流通チャネル別

  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第9章 欧州のマラリア治療薬市場：国別分析

  • 欧州
  • フランス
  • 英国
  • イタリア
  • ドイツ
  • スペイン
  • その他欧州

第10章 マラリア治療市場の業界情勢

  • マラリア治療市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd

第12章 付録

図表

List Of Tables

  • Table 1. Malaria Treatment Market Segmentation
  • Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
  • Table 3. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 5. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 6. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 7. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 8. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 9. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 10. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 11. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 12. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 13. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 14. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 15. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 16. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 17. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 18. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 19. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 20. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 21. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 22. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 24. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 25. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 26. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 27. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 28. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 29. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 30. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 31. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 32. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 33. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 35. Recent Inorganic Growth Strategies in the Malaria Treatment Market
  • Table 36. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 37. Glossary of Terms, Malaria Treatment Market

List Of Figures

  • Figure 1. Malaria Treatment Market - Key Industry Dynamics
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030
  • Figure 4. Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 9. Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Europe Malaria Treatment Market, By Country, 2022 ($Mn)
  • Figure 19. Europe: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
  • Figure 20. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 21. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 22. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Growth Strategies in the Malaria Treatment Market
目次
Product Code: TIPRE00025038

The Europe malaria treatment market was valued at US$ 451.69 million in 2022 and is expected to reach US$ 3,060.97 million by 2030; it is estimated to grow at a CAGR of 27.0% from 2022 to 2030.

Extending Pipeline of New Drugs and Vaccines Drives Europe Malaria Treatment Market

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

A few antimalarial that are under clinical development are mentioned in the table below:

  • Table 1. Malaria Drugs/Vaccine/Compounds Under Clinical Development

Drug Developer Clinical Trial Stage

Artefenomel Sanofi Phase IIb

KAE609 Novartis AG Phase IIb

KAF156 Novartis AG Phase IIb

DSM265 Takeda Pharmaceutical Company Phase IIa

SANARIA PfSPZ-GA1 Sanaria Phase II

SANARIA PfSPZ Vaccine - Radiation Attenuated PfSPZ Vaccine Sanaria Phase II

SANARIA PfSPZ-CVac Sanaria Phase II

MSP3-CRM-Vac4All Vac4All Phase I

Liver-Stage Antigen-3 (LSA3) Vac4All Phase IIa

Source: Company Website, The Insight Partners Analysis

Therefore, the growing number of antimalarial and drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

Europe Malaria Treatment Market Overview

According to a surveillance report by ECDC, France reported the highest number of malaria cases in 2020. In 2020, France reported 1,007 confirmed malaria cases. Nearly all the cases reported by EU/EEA countries in 2020 were diagnosed in people traveling to France from other countries; these mostly included individuals linked to travel routes from West Africa. In France, P. falciparum is responsible for almost all severe cases and deaths in travelers. Many research organizations are working toward developing new approaches to eliminate malaria in France. For example, teams at the Institut Pasteur are dedicated to malaria research aiming to develop vaccines. This research is vital in finding new ways of fighting malaria. The Institute Pasteur is also taking part in a major European program named EVIMalaR, which involves 17 research institutes and universities from 7 European countries, and partners from 3 African countries. Such collaborative efforts toward malaria elimination are driving the growth of the malaria treatment market in France.

Europe Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Malaria Treatment Market Segmentation

The Europe malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Europe malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The generic drugs segment held the largest market share in 2022.

In terms of route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the Europe malaria treatment market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd are some of the leading players operating in the Europe malaria treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights - Malaria

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Malaria Treatment Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Malaria
  • 4.2 Market Restraints
    • 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
  • 4.3 Market Opportunities
    • 4.3.1 Growing Strategic Initiatives by Market Players
  • 4.4 Future Trends
    • 4.4.1 Extending Pipeline of New Drugs and Vaccines
  • 4.5 Impact Analysis

5. Malaria Treatment Market - Europe Market Analysis

  • 5.1 Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • 6.3 Vaccines
    • 6.3.1 Overview
    • 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
  • 6.4 Generic Drugs
    • 6.4.1 Overview
    • 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
  • 6.5 Originators
    • 6.5.1 Overview
    • 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

  • 7.1 Overview
  • 7.2 Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • 7.3 Oral
    • 7.3.1 Overview
    • 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Parenteral
    • 7.4.1 Overview
    • 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 8.1 Overview
  • 8.2 Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 8.3 Direct Tender
    • 8.3.1 Overview
    • 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hospital Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
  • 8.5 Retail Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
  • 8.6 Online Pharmacies
    • 8.6.1 Overview
    • 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Malaria Treatment Market - Country Analysis

  • 9.1 Europe Malaria Treatment Market, Revenue and Forecast to 2030
    • 9.1.1 Overview
      • 9.1.1.1 Europe: Malaria Treatment Market, by Countries
      • 9.1.1.2 France
      • 9.1.1.3 Overview
        • 9.1.1.3.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.2 France: Malaria Treatment Market, by Treatment
        • 9.1.1.3.3 France: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.3.4 France: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.3.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.3.4.2 France: Malaria Treatment Market, by Retail Pharmacies
      • 9.1.1.4 UK
      • 9.1.1.5 Overview
        • 9.1.1.5.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.2 UK: Malaria Treatment Market, by Treatment
        • 9.1.1.5.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.5.4 UK: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.5.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.5.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
      • 9.1.1.6 Italy
      • 9.1.1.7 Overview
        • 9.1.1.7.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.7.2 Italy: Malaria Treatment Market, by Treatment
        • 9.1.1.7.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.7.4 Italy: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.7.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.7.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
      • 9.1.1.8 Germany
      • 9.1.1.9 Overview
        • 9.1.1.9.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.9.2 Germany: Malaria Treatment Market, by Treatment
        • 9.1.1.9.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.9.4 Germany: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.9.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.9.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
      • 9.1.1.10 Spain
      • 9.1.1.11 Overview
        • 9.1.1.11.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.11.2 Spain: Malaria Treatment Market, by Treatment
        • 9.1.1.11.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.11.4 Spain: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.11.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.11.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
      • 9.1.1.12 Rest of Europe
      • 9.1.1.13 Overview
        • 9.1.1.13.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.13.2 Rest of Europe: Malaria Treatment Market, by Treatment
        • 9.1.1.13.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.13.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.13.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.13.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Malaria Treatment Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Cipla Ltd
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Sun Pharmaceutical Industries Ltd
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Sanofi SA
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 GSK Plc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Novartis AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Pfizer Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Service
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Lupin Ltd
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms